Skip to main content

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in NVO — Novo Nordisk A S

CIK 1021223 LOS ANGELES, CA

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,382,062
+$275,152 QoQ
Shares Held
28,829
-4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#449
of 1,348 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. NVO ranks #8 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
28,829 $1,382,062

All Filings in NVO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,382,062 28,829
2026-03-31 $1,106,910 30,120
2025-12-31 $1,160,521 22,809
2025-09-30 $1,874,063 33,773
2025-06-30 $1,592,153 23,068
2025-03-31 $1,690,586 24,346
2024-12-31 $2,216,993 25,773
2024-09-30 $3,175,239 26,667
2024-06-30 $5,225,425 36,608
2024-03-31 $5,677,077 44,214
2023-12-31 $5,323,019 51,455
2023-09-30 $4,336,564 47,686
2023-06-30 $4,275,063 26,417
2023-03-31 $4,004,598 25,164
2022-12-31 $2,795,989 20,659
2022-09-30 $1,685,938 16,922
2022-03-31 $4,997 45